Monkeypox vaccine race: Portugal defines strategy to control outbreak – Sociedade
There are at least three countries that are preparing to order thousands of doses of vaccines against common smallpox, known to have cases of monkeypox (monkeypox) in humans.
In Europe, Spain has already ordered thousands of doses of Imvanex, developed by the Danish laboratory Bavarian Nordik. This has been authorized by the European Medicines Agency since 2013 and is intended for the common vaccine, considered eradicated from the planet since 1980. In Spain, the vaccines will be applied to close contacts of infected people.
The vaccine “is approved for the prevention of human and monkey smallpox.” The monkey varie is zoonosis that, once humans, can be transferred from animals to humans (especially from gnawing like squirrels) are animals.
The vaccine is not a specific drug” for this disease, but it can be attempted” in its prevention “, considers the president of the Spanish Association of Vaccinology (AEV) “Fernando Moraga-L.
Also in the United States, the administration of American President Joe Biden placed an American order of 118 million euros to deal with a potential increase in cases.
In the UK as vaccine vaccines also vaccinate for health in contact with positive cases.
In Portugal, the Directorate-General for Health informed Correio da Manhã that “it is in direct contact with the Medicines Authority – Infarmed, with national and international experts such as the World Health Organization, in order to be the best strategy for defining control of this outbreak”.
Recommends using common for already infected high-risk contacts.